Mach7 Technologies 향후 성장

Future 기준 점검 1/6

Mach7 Technologies (는) 각각 연간 34.9% 및 11.1% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 44.4% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 -3.6% 로 예상됩니다.

핵심 정보

34.9%

이익 성장률

44.41%

EPS 성장률

Healthcare Services 이익 성장	22.8%
매출 성장률	11.1%
향후 자기자본이익률	-3.58%
애널리스트 커버리지	Low
마지막 업데이트	03 Oct 2025

최근 향후 성장 업데이트

Recent updates

Mach7 Technologies Limited (ASX:M7T) Looks Inexpensive But Perhaps Not Attractive Enough

Jul 21

Revenues Working Against Mach7 Technologies Limited's (ASX:M7T) Share Price Following 27% Dive

Apr 06

We're Interested To See How Mach7 Technologies (ASX:M7T) Uses Its Cash Hoard To Grow

Mar 13

Mach7 Technologies Limited (ASX:M7T) Held Back By Insufficient Growth Even After Shares Climb 32%

Feb 19

Little Excitement Around Mach7 Technologies Limited's (ASX:M7T) Revenues As Shares Take 29% Pounding

Nov 06

Mach7 Technologies Limited (ASX:M7T) Just Reported And Analysts Have Been Cutting Their Estimates

Aug 30

Investors Interested In Mach7 Technologies Limited's (ASX:M7T) Revenues

Aug 01

Mach7 Technologies Limited (ASX:M7T) Analysts Are More Bearish Than They Used To Be

Jan 29

We're Interested To See How Mach7 Technologies (ASX:M7T) Uses Its Cash Hoard To Grow

Apr 28

An Intrinsic Calculation For Mach7 Technologies Limited (ASX:M7T) Suggests It's 47% Undervalued

Oct 24

Are Investors Undervaluing Mach7 Technologies Limited (ASX:M7T) By 37%?

Jun 23

Is Mach7 Technologies Limited (ASX:M7T) Potentially Undervalued?

May 19

Is There An Opportunity With Mach7 Technologies Limited's (ASX:M7T) 47% Undervaluation?

Nov 10

Mach7 Technologies Limited's (ASX:M7T) Analyst Just Slashed This Year's Estimates

Jul 27

Upgrade: The Latest Revenue Forecasts For Mach7 Technologies Limited (ASX:M7T)

Feb 19

이익 및 매출 성장 예측

ASX:M7T - 애널리스트 향후 추정치 및 과거 재무 데이터 (AUD Millions)
날짜	매출	이익	자유현금흐름	영업현금흐름	평균 애널리스트 수
6/30/2028	47	-2	N/A	3	2
6/30/2027	42	-5	N/A	1	2
6/30/2026	38	-6	N/A	-1	2
6/30/2025	34	-6	-1	1	N/A
3/31/2025	34	-6	-1	1	N/A
12/31/2024	34	-5	0	1	N/A
9/30/2024	31	-7	1	2	N/A
6/30/2024	29	-8	3	3	N/A
3/31/2024	28	-7	3	3	N/A
12/31/2023	27	-6	2	2	N/A
9/30/2023	29	-3	0	0	N/A
6/30/2023	30	-1	-3	-3	N/A
3/31/2023	29	-2	-2	-1	N/A
12/31/2022	28	-4	0	0	N/A
9/30/2022	27	-4	3	3	N/A
6/30/2022	26	-4	6	6	N/A
3/31/2022	26	-3	5	6	N/A
12/31/2021	26	-3	5	5	N/A
9/30/2021	23	-6	3	3	N/A
6/30/2021	19	-9	1	1	N/A
3/31/2021	18	-9	1	1	N/A
12/31/2020	17	-8	0	0	N/A
9/30/2020	18	-4	2	3	N/A
6/30/2020	19	0	5	5	N/A
3/31/2020	17	-1	3	3	N/A
12/31/2019	15	-2	1	1	N/A
9/30/2019	12	-5	-1	-1	N/A
6/30/2019	9	-7	-3	-3	N/A
3/31/2019	9	-7	N/A	-4	N/A
12/31/2018	8	-6	N/A	-4	N/A
9/30/2018	8	-5	N/A	-3	N/A
6/30/2018	9	-5	N/A	-2	N/A
3/31/2018	9	-11	N/A	-2	N/A
12/31/2017	9	-17	N/A	-3	N/A
9/30/2017	10	-17	N/A	-4	N/A
6/30/2017	10	-18	N/A	-5	N/A
3/31/2017	8	-16	N/A	-5	N/A
12/31/2016	6	-15	N/A	-4	N/A
9/30/2016	4	-14	N/A	-4	N/A
6/30/2016	2	-13	N/A	-3	N/A
12/31/2015	8	-3	N/A	N/A	N/A
6/30/2015	0	-7	N/A	-2	N/A
12/31/2014	5	-3	N/A	N/A	N/A

애널리스트 향후 성장 전망

수입 대 저축률: M7T 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 vs 시장: M7T 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

고성장 수익: M7T 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 대 시장: M7T 의 수익(연간 11.1%)이 Australian 시장(연간 5.8%)보다 빠르게 성장할 것으로 예상됩니다.

고성장 매출: M7T 의 수익(연간 11.1%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.

주당순이익 성장 예측

향후 자기자본이익률

미래 ROE: M7T는 3년 뒤에도 수익성이 없을 것으로 전망됩니다.

성장 기업 찾아보기

기업 분석 및 재무 데이터 상태

데이터	최종 업데이트 (UTC 시간)
기업 분석	2025/10/07 07:56
종가	2025/10/07 00:00
수익	2025/06/30
연간 수익	2025/06/30

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
기업 재무제표	10년	손익계산서 현금흐름표 대차대조표	SEC 양식 10-K SEC 양식 10-Q
분석가 컨센서스 추정치	+3년	재무 예측 분석가 목표주가	분석가 리서치 보고서 Blue Matrix
시장 가격	30년	주가 배당, 분할 및 기타 조치	ICE 시장 데이터 SEC 양식 S-1
지분 구조	10년	주요 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
경영진	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발	10년	회사 공시	SEC 양식 8-K

^* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 Github 페이지에서 확인할 수 있으며, 보고서 활용 방법에 대한 가이드와 Youtube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Mach7 Technologies Limited는 12명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가	기관
Scott Power	CGS International
ZheWei Sim	Jefferies LLC
David Low	J.P. Morgan

Mach7 Technologies 향후 성장

Future 기준 점검 1/6

핵심 정보

최근 향후 성장 업데이트

Forecast to breakeven in 2028

Price target decreased by 16% to AU$0.73

Mach7 Technologies Limited Provides Preliminary Unaudited Earnings Guidance for the Year Ended June 30, 2025

No longer forecast to breakeven

Price target decreased by 11% to AU$1.04

Consensus EPS estimates fall by 480%

Recent updates

Mach7 Technologies Limited, Annual General Meeting, Nov 28, 2025

New minor risk - Profitability

Forecast to breakeven in 2028

Price target decreased by 16% to AU$0.73

Mach7 Technologies Limited to Report Fiscal Year 2025 Results on Aug 27, 2025

Mach7 Technologies Limited (ASX:M7T) Looks Inexpensive But Perhaps Not Attractive Enough

Mach7 Technologies Limited Provides Preliminary Unaudited Earnings Guidance for the Year Ended June 30, 2025

No longer forecast to breakeven

Price target decreased by 11% to AU$1.04

Mach7 Technologies Limited to Report Q3, 2025 Results on Apr 29, 2025

Revenues Working Against Mach7 Technologies Limited's (ASX:M7T) Share Price Following 27% Dive

We're Interested To See How Mach7 Technologies (ASX:M7T) Uses Its Cash Hoard To Grow

First half 2025 earnings: EPS and revenues exceed analyst expectations

Mach7 Technologies Announces Product Launch of the Eunity Diagnostic Image Viewer Using Aws Healthimaging

Mach7 Technologies Limited (ASX:M7T) Held Back By Insufficient Growth Even After Shares Climb 32%

Mach7 Technologies Limited to Report First Half, 2025 Results on Feb 27, 2025

Mach7 Technologies Limited (ASX:M7T) announces an Equity Buyback for 24,124,104 shares, representing 10% for AUD 5 million.

Mach7 Technologies Limited to Report Q2, 2025 Results on Jan 31, 2025

Independent Non-Executive Director recently bought AU$228k worth of stock

Mach7 Technologies Introduces UnityVue, A Next-Generation Radiology Reading Solution with Groundbreaking Capabilities

Little Excitement Around Mach7 Technologies Limited's (ASX:M7T) Revenues As Shares Take 29% Pounding

Mach7 Technologies Limited to Report Q1, 2025 Results on Oct 31, 2024

Mach7 Technologies Limited, Annual General Meeting, Nov 28, 2024

Consensus EPS estimates fall by 480%

Mach7 Technologies Limited (ASX:M7T) Just Reported And Analysts Have Been Cutting Their Estimates

Price target decreased by 8.0% to AU$1.13

Forecast breakeven date pushed back to 2027

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Investors Interested In Mach7 Technologies Limited's (ASX:M7T) Revenues

Mach7 Technologies Limited to Report Fiscal Year 2024 Results on Aug 28, 2024

Mach7 Technologies Limited to Report Q4, 2024 Results on Jul 30, 2024

Now 25% undervalued after recent price drop

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Mach7 Technologies Limited to Report Q3, 2024 Results on Apr 24, 2024

Mach7 Technologies Limited to Report First Half, 2024 Results on Feb 29, 2024

Mach7 Technologies Limited (ASX:M7T) Analysts Are More Bearish Than They Used To Be

Consensus EPS estimates fall by 120%

Forecast breakeven date pushed back to 2026

Mach7 Technologies Limited to Report Q2, 2024 Results on Jan 31, 2024

Price target decreased by 7.6% to AU$1.23

Mach7 Technologies (ASX:M7T) Is In A Strong Position To Grow Its Business

Insufficient new directors

Mach7 Technologies Limited Appoints Rebecca Thompson as Director

Independent Non-Executive Director exercised options to buy AU$158k worth of stock.

Consensus EPS estimates upgraded to AU$0.0045 loss, revenue downgraded

Mach7 Technologies Limited to Report Q1, 2024 Results on Oct 31, 2023

New minor risk - Market cap size

Price target decreased by 9.7% to AU$1.33

Is Now The Time To Look At Buying Mach7 Technologies Limited (ASX:M7T)?

CEO, MD & Director exercised options and sold AU$65k worth of stock

Mach7 Technologies Limited Announces Board Changes, Effective 16 November 2023

Estimating The Fair Value Of Mach7 Technologies Limited (ASX:M7T)

Forecast breakeven date pushed back to 2025

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

New minor risk - Financial data availability

Mach7 Technologies Limited to Report Fiscal Year 2023 Results on Aug 31, 2023

Mach7 Technologies Limited, Annual General Meeting, Nov 16, 2023

Mach7 Technologies Limited to Report Q4, 2023 Results on Jul 31, 2023

Price target increased by 13% to AU$1.49

Independent Non-Executive Chairman exercised options to buy AU$140k worth of stock.

Why Mach7 Technologies Limited (ASX:M7T) Could Be Worth Watching

Now 21% undervalued after recent price drop

We're Interested To See How Mach7 Technologies (ASX:M7T) Uses Its Cash Hoard To Grow

Now 20% undervalued after recent price drop

First half 2023 earnings released: AU$0.001 loss per share (vs AU$0.002 loss in 1H 2022)

Consensus EPS estimates upgraded to AU$0.009 loss, revenue downgraded

Mach7 Technologies Limited Announces Change of Company Secretary